mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Maruggi, Giulietta; Zhang, Cuiling; Li, Junwei; Ulmer, Jeffrey B; Yu, Dong

Maruggi, Giulietta; Zhang, Cuiling; Li, Junwei; Ulmer, Jeffrey B; Yu, Dong.

Affiliation

Maruggi G; GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA. Electronic address: giulietta.x.maruggi@gsk.com.
Zhang C; College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Li J; College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Ulmer JB; GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA.
Yu D; GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA. Electronic address: dong.x.yu@gsk.com.

Mol Ther ; 27(4): 757-772, 2019 04 10.

Article in En | MEDLINE | ID: mdl-30803823

Subject(s)

Communicable Disease Control/methods; RNA, Messenger/administration & dosage; RNA, Messenger/genetics; Vaccination/methods; Vaccines, Synthetic/genetics; Animals; Cancer Vaccines; Drug Delivery Systems/methods; Humans; Lipids/chemistry; Nanoparticles/chemistry

Key words

RNA-based vaccine; infectious diseases; self-amplifying mRNA; synthetic vaccine; vaccine on demand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Vaccines, Synthetic / Communicable Disease Control / Vaccination Aspects: Determinantes_sociais_saude Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google